Skip to main content
. 2006 Apr 10;65(11):1512–1517. doi: 10.1136/ard.2005.049924

Table 5 Association between size of the CD4+ CD25high population and use of corticosteroids.

CD4+ CD25high (%) Corticosteroids Univariate analysis, OR (95% CI), p value* Multivariate analysis†, OR (95% CI), p value*
Non–users, n (%) Users, n (%)
Low (<8.4) 43 (58.9) 30 (41.1)
High (⩾8.4) 11 (29.7) 26 (70.3) 3.39 (1.45 to 7.88) 0.005 3.59 (1.35 to 9.51) 0.010

*Calculated by unconditional binary logistic regression modelling, using the percentage of CD4+ CD25high T cells as the dependent variable and patients without glucocorticoid treatment as reference.

†Adjusted for clinical parameters: malar rash, discoid lesions, photosensitivity, oral ulcers, arthritis, serositis, renal, neurological or haematological disorder, and level of anti‐double‐stranded DNA antibodies at the time of sampling.

HHS Vulnerability Disclosure